PTX 0.00% 4.0¢ prescient therapeutics limited

Ann: Encouraging Pre-Clinical Data Presented at US Cancer Meeting, page-2

  1. 2,863 Posts.
    lightbulb Created with Sketch. 26
    PTX-100 reduced multiple myeloma tumours AND sensitised multiple myeloma cells in mice models.

    Should see buyers return to the stock as the data is presented today at the Cancer Research Meeting.

    EV value of $2M is absurd given the trials both pending and underway.

    Even at 16c the stock would still be cheap compared to its ASX peers.

    Cheers.

    .
 
watchlist Created with Sketch. Add PTX (ASX) to my watchlist
(20min delay)
Last
4.0¢
Change
0.000(0.00%)
Mkt cap ! $32.21M
Open High Low Value Volume
4.0¢ 4.1¢ 4.0¢ $3.084K 76.05K

Buyers (Bids)

No. Vol. Price($)
2 261360 4.0¢
 

Sellers (Offers)

Price($) Vol. No.
4.1¢ 696141 7
View Market Depth
Last trade - 10.53am 21/06/2024 (20 minute delay) ?
PTX (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.